Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
CVS Health Foundation grants $4 million as part of its new healthy aging initiative PR Newswire WOONSOCKET, R.I., Jan. 23, 2025 Funding will support organizations serving older adults in Atlanta...
CVS Health to hold fourth quarter and full year 2024 earnings conference call PR Newswire WOONSOCKET, R.I., Jan. 13, 2025 WOONSOCKET, R.I., Jan. 13, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS...
CVS Health supporting customers, patients, members and colleagues amid California wildfires PR Newswire WOONSOCKET, R.I., Jan. 10, 2025 WOONSOCKET, R.I., Jan. 10, 2025 /PRNewswire/ -- CVS...
CVS Pharmacy achieves CVS CostVantage milestone PR Newswire WOONSOCKET, R.I., Jan. 6, 2025 All commercial prescriptions dispensed at CVS Pharmacy will be reimbursed through CVS CostVantage...
CVS Health announces quarterly dividend PR Newswire WOONSOCKET, R.I., Jan. 3, 2025 WOONSOCKET, R.I., Jan. 3, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors...
Varo Bank Introduces Zero Fee Cash Deposits at Participating CVS Locations PR Newswire AUSTIN, Texas and SAN FRANCISCO, Dec. 20, 2024 New Collaboration with Green Dot Enables Cash Deposits at...
Aetna Adds Spanish Language Capabilities for Health App to Better Serve Diverse Populations PR Newswire HARTFORD, Conn., Dec. 19, 2024 HARTFORD, Conn., Dec. 19, 2024 /PRNewswire/ -- Aetna, a CVS...
CVS Health Corporation Announces Pricing of Maximum Tender Offer PR Newswire WOONSOCKET, R.I., Dec. 16, 2024 WOONSOCKET, R.I., Dec. 16, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health...
CVS Health Corporation Announces Early Results of Maximum Tender Offer and Election of Early Settlement PR Newswire WOONSOCKET, R.I., Dec. 16, 2024 WOONSOCKET, R.I., Dec. 16, 2024 /PRNewswire/...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
